Differential activation of eosinophils by 'probiotic' Bifidobacterium bifidum and 'pathogenic' Clostridium difficile

International Archives of Allergy and Immunology

Volumn 152, Issue SUPPL. 1, 2010, Pages 83-89

  Hosoki, Koa ^a   Nakamura, Akiko ^a   Nagao, Mizuho ^a   Hiraguchi, Yukiko ^a   Tokuda, Reiko ^a   Wada, Hideo ^a   Nobori, Tsutomu ^a   Fujisawa, Takao ^a  

^a MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bifidobacterium bifidum; Clostridium difficile; Food allergy; Human eosinophils; Inflammatory bowel disease; Probiotics

Indexed keywords

CYTOCHROME C; NEUROTOXIN; PROBIOTIC AGENT; SUPEROXIDE;

BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; CELL ACTIVATION; CELL FUNCTION; CLOSTRIDIUM DIFFICILE; CONFERENCE PAPER; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEGRANULATION; DRUG EFFECT; EOSINOPHIL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; PRIORITY JOURNAL;

BIFIDOBACTERIUM; CELL DEGRANULATION; CLOSTRIDIUM DIFFICILE; EGTAZIC ACID; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNE SYSTEM PROCESSES; PERTUSSIS TOXIN; PHAGOCYTOSIS; PROBIOTICS; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953273526     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312131     Document Type: Conference Paper

References (45)

1. Sanders ME: Probiotics: considerations for human health. Nutr Rev 2003; 61: 91-99.
2. Vanderpool C, Yan F, Polk DB: Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008; 14: 1585-1596.
3. Suzuki S, Shimojo N, Tajiri Y, Kumemura M, Kohno Y: Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 2007; 37: 506-511.
4. Bjorksten B, Naaber P, Sepp E, Mikelsaar M: The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29: 342-346.
5. Sepp E, Julge K, Mikelsaar M, Bjorksten B: Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005; 35: 1141-1146.
6. Murray CS, Tannock GW, Simon MA, Harmsen HJ, Welling GW, Custovic A, Woodcock A: Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy 2005; 35: 741-745.
7. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M: Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003; 111: 587-591.
8. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108: 516-520. (Pubitemid 32978019)
9. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S: Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001; 108: 144-145.
10. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E: Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134.
11. Prescott SL, Bjorksten B: Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007; 120: 255-262.
12. Lee J, Seto D, Bielory L: Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008; 121: 116-121e111.
13. Ewaschuk JB, Dieleman LA: Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol 2006; 12: 5941-5950.
14. Isaacs K, Herfarth H: Role of probiotic therapy in IBD. Inflamm Bowel Dis 2008; 14: 1597-1605.
15. Hedin C, Whelan K, Lindsay JO: Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007; 66: 307-315.
16. Nguyen GC, Kaplan GG, Harris ML, Brant SR: A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 1443-1450.
17. Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG: Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 345-351.
18. Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD: Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 339-344.
19. Freeman HJ: Recent developments on the role of Clostridium difficile in inflammatory bowel disease. World J Gastroenterol 2008; 14: 2794-2796.
20. Wedemeyer J, Vosskuhl K: Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours. Best Pract Res Clin Gastroenterol 2008; 22: 537-549.
21. Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, de Freitas FC, Lapa e Silva JR: Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003; 36: 120-125.
22. Majamaa H, Laine S, Miettinen A: Eosinophil protein X and eosinophil cationic protein as indicators of intestinal inflammation in infants with atopic eczema and food allergy. Clin Exp Allergy 1999; 29: 1502-1506.
23. Majamaa H, Miettinen A, Laine S, Isolauri E: Intestinal inflammation in children with atopic eczema: faecal eosinophil cationic protein and tumour necrosis factor-alpha as non-invasive indicators of food allergy. Clin Exp Allergy 1996; 26: 181-187.
24. Schwab D, Muller S, Aigner T, Neureiter D, Kirchner T, Hahn EG, Raithel M: Functional and morphologic characterization of eosinophils in the lower intestinal mucosa of patients with food allergy. Am J Gastroenterol 2003; 98: 1525-1534.
25. Kosnai I, Kuitunen P, Savilahti E, Sipponen P: Mast cells and eosinophils in the jejunal mucosa of patients with intestinal cow's milk allergy and celiac disease of childhood. J Pediatr Gastroenterol Nutr 1984; 3: 368-372.
26. Rothenberg ME: Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004; 113: 11-28, quiz 29.
27. Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H: Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005; 175: 5439-5447.
28. Takeuchi M, Tatsumi Y, Kitaichi K, Baba K, Suzuki R, Shibata E, Takagi K, Miyamoto K, Hasegawa T: Selective phosphodiesterase type 4 inhibitors reduce the prolonged survival of eosinophils stimulated by granulocyte-macrophage colony-stimulating factor. Biol Pharm Bull 2002; 25: 184-187.
29. Horie S, Gleich GJ, Kita H: Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 1996; 98: 371-381.
30. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K: Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 2000; 106: 507-513.
31. Weil GJ, Chused TM: Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood 1981; 57: 1099-1104.
32. Nagata M, Sedgwick JB, Kita H, Busse WW: Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol 1998; 19: 158-166.
33. Chung HL, Hwang JB, Kwon YD, Park MH, Shin WJ, Park JB: Deposition of eosinophilgranule major basic protein and expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the mucosa of the small intestine in infants with cow's milk-sensitive enteropathy. J Allergy Clin Immunol 1999; 103: 1195-1201.
34. Bengtsson U, Knutson TW, Knutson L, Dannaeus A, Hallgren R, Ahlstedt S: Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance. J Allergy Clin Immunol 1997; 100: 216-221.
35. Saarinen KM, Sarnesto A, Savilahti E: Markers of inflammation in the feces of infants with cow's milk allergy. Pediatr Allergy Immunol 2002; 13: 188-194.
36. Raab Y, Fredens K, Gerdin B, Hallgren R: Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci 1998; 43: 1061-1070.
37. Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjo H, Carlson M: Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scand J Clin Lab Invest 2007; 67: 810-820.
38. Carlson M, Raab Y, Peterson C, Hallgren R, Venge P: Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol 1999; 94: 1876-1883.
39. Levy AM, Gleich GJ, Sandborn WJ, Tremaine WJ, Steiner BL, Phillips SF: Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc 1997; 72: 117-123.
40. Furuta GT, Nieuwenhuis EE, Karhausen J, Gleich G, Blumberg RS, Lee JJ, Ackerman SJ: Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 2005; 289:G890-G897.
41. Pascarella F, Martinelli M, Miele E, Pezzo MD, Roscetto E, Staiano A: Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009; 154:854-858.
42. Matthews AN, Friend DS, Zimmermann N, Sarafi MN, Luster AD, Pearlman E, Wert SE, Rothenberg ME: Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA 1998; 95: 6273-6278.
43. Furuta GT: Emerging questions regarding eosinophil's role in the esophago-gastrointestinal tract. Curr Opin Gastroenterol 2006; 22: 658-663.
44. Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME: A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci USA 2000; 97: 6681-6686.
45. Bischoff SC, Grabowsky J, Manns MP: Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 1997; 42: 394-403.